Astrazeneca PLC Sponsored ADR (AZN)

57.98
0.09 0.16
NASDAQ
Prev Close 57.89
Open 58.85
Day Low/High 57.88 / 58.85
52 Wk Low/High 36.15 / 64.94
Volume 5.77M
Exchange NASDAQ
P/E Ratio 51.70
Div & Yield N.A. (N.A)

Latest News

AstraZeneca Is Moving the Needle

AstraZeneca Is Moving the Needle

This drugmaker is making a historic upside breakout. Let's check the charts.

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.

Agility Rules, Spoiled Whiners, Smell the May Flowers, Ford in My Future

Agility Rules, Spoiled Whiners, Smell the May Flowers, Ford in My Future

Plus, ServiceNow is a stock worth stalking and Amazon is a stock worth celebrating.

Market Turbulence, Credible FOMC?, GDP, Heavy Earnings Week, COVID in India

Market Turbulence, Credible FOMC?, GDP, Heavy Earnings Week, COVID in India

So far, for the season, the blended rate of earnings growth for the first quarter now stands at an incredible 33.8%.

I'm Not Bailing on Johnson & Johnson Now

I'm Not Bailing on Johnson & Johnson Now

Don't forget, this is a very large company with a lot more than the vaccine going on.

Here's Why I'm Avoiding AstraZeneca Stock

Here's Why I'm Avoiding AstraZeneca Stock

The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.

Have I Been Given a Dodgy Pfizer Shot in Hong Kong?

Have I Been Given a Dodgy Pfizer Shot in Hong Kong?

Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.

Market Moves, Nasdaq, Be Amphibious, FedCoin, Powell & Yellen, Trading Best Buy

Market Moves, Nasdaq, Be Amphibious, FedCoin, Powell & Yellen, Trading Best Buy

Ever think you would see the day when all cash was digital so the federal government could place a negative interest rate (tax) on savings? I can see this coming from a mile away.

Should You Buy AstraZeneca After Its Positive Vaccine News?

Should You Buy AstraZeneca After Its Positive Vaccine News?

Here's my view on this space and where the money is to be made.

Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD

Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD

COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?

Emergent BioSolutions Turns Bearish, So Beware

Emergent BioSolutions Turns Bearish, So Beware

A break in a key support level could precipitate further declines in the life sciences company's shares.

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

Who knew high finance was so easy? And why the heck was I working so hard? Fundamental analysis is so 1980s.

Lunchtime Reading

Here are some articles that I'll be perusing while I choke down my lunch today:  American Airlines Uncorks Wine Delivery Program To Clear Shelves, Promote Travel MyFreeCams hack: 2 million user records stolen from top adult streaming site and sold o...

The Correction in AstraZeneca Could Be Nearing an End

The Correction in AstraZeneca Could Be Nearing an End

Aggressive traders might want to look past any near-term price weakness and consider a small long position.

Jim Cramer: Here's My Plan to Distribute the Vaccine

Jim Cramer: Here's My Plan to Distribute the Vaccine

We have to take both the private sector and the states out of the equation, and adopt the process that wiped out Polio.

Assessing AstraZeneca in the Fight Against the Virus

Assessing AstraZeneca in the Fight Against the Virus

While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.

$2000 Delayed, Covid-19 Mutation, Trading Intel

$2000 Delayed, Covid-19 Mutation, Trading Intel

I did something on Tuesday that I never thought that I would do again. I bought some Intel.

I've Come Around to Thinking of Boeing as an Investment

I've Come Around to Thinking of Boeing as an Investment

I think BA returns to normal as we do, as the airlines do... but with the defense contracting business as a foundation to rely upon.

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Ending the pandemic swiftly appears unlikely, so here's how to look at key stocks and sectors right now -- especially as concerns of new lockdowns grow.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.

Real Money Post Industrial Average Climbs 9.5% Over November

Real Money Post Industrial Average Climbs 9.5% Over November

The RMPIA also tops other indexes for year, shooting ahead 29%.